scispace - formally typeset
M

Michael Kremer

Researcher at Harvard University

Publications -  324
Citations -  33149

Michael Kremer is an academic researcher from Harvard University. The author has contributed to research in topics: Population & Incentive. The author has an hindex of 78, co-authored 294 publications receiving 29375 citations. Previous affiliations of Michael Kremer include National Bureau of Economic Research & Center for Global Development.

Papers
More filters
ReportDOI

School Vouchers, Labor Markets and Vocational Education

TL;DR: The authors studied the impact of the PACES program on the bienestar social, económico, and socio-economic, of alumnos of bajos recursos.
Posted Content

Advanced Purchase Commitments for a Malaria Vaccine: Estimating Costs and Effectiveness

TL;DR: In this paper, the authors estimate the offer size which would make the revenues from R&D investments on a malaria vaccine similar to revenues realized from investments in typical existing commercial pharmaceutical products, as well as the degree to which various contract models and assumptions would affect the cost-effectiveness of such a commitment for the case of a vaccine.
Posted Content

Many Children Left Behind? Textbooks and Test Scores in Kenya

TL;DR: In this article, a randomized evaluation suggests that a program which provided official textbooks to randomly selected rural Kenyan primary schools did not increase test scores for the average student, and the results are consistent with the hypothesis that the Kenyan education system and curricular materials are oriented to the academically strongest students rather than to typical students.
Journal ArticleDOI

Guns, Latrines, and Land Reform: Dynamic Pigouvian Taxation

TL;DR: In a dynamic game, consumers may delay purchasing durables with positive externalities, such as latrines, anticipating greater future subsidies as discussed by the authors, potentially causing policymakers who would otherwise prefer taxes or regulation to abandon such policies.
Journal ArticleDOI

Preparing for a Pandemic: Accelerating Vaccine Availability

TL;DR: In this paper, the authors analyze the problem faced by governments in determining the scale and structure of procurement for vaccines and find that if the goal is to accelerate the vaccine delivery timetable, buyers should directly fund manufacturing capacity and shoulder most of the risk of failure.